Bioretec earns market authorization for its RemeOs trauma screw

Orthopedic

Bioretec, a developer of bioresorbable orthopedic implants, has earned market authorization for its RemeOs trauma screw in the U.S. 

RemeOs is the first and only bioresorbable metal implant approved by the FDA, with successful clinical trials conducted in the ankle, according to a March 30 press release. 

Bioretec plans to launch the screw in the U.S. in collaboration with hospitals and professionals specializing in ankle fractures. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers